Mölnlycke Health Care, commonly referred to as Mölnlycke, is a leading global provider of wound care and surgical solutions, headquartered in Sweden (SE). Founded in 1849, the company has established a strong presence in Europe, North America, and Asia, focusing on innovative products that enhance patient outcomes. Mölnlycke is renowned for its advanced wound care products, including the Mepilex® range of foam dressings and the Safetac® technology, which minimises pain during dressing changes. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, achieving notable milestones such as ISO certification and recognition for its sustainability efforts. With a robust market position, Mölnlycke continues to lead the industry by prioritising patient safety and comfort, making significant contributions to the fields of wound management and surgical care.
How does Molnlycke's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Molnlycke's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Mölnlycke Health Care reported total greenhouse gas emissions of approximately 549,129,000 kg CO2e. This includes Scope 1 emissions of about 52,356,000 kg CO2e, Scope 2 emissions of approximately 10,513,000 kg CO2e (market-based), and significant Scope 3 emissions totalling around 486,261,000 kg CO2e. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (approximately 312,323,000 kg CO2e) and upstream transportation and distribution (about 41,254,000 kg CO2e). Mölnlycke has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 50% by 2030 from a 2021 baseline. Additionally, they have committed to achieving a 90% reduction in these emissions by 2050. For Scope 3 emissions, the company targets a 20% reduction by 2028 from the same baseline year. Furthermore, Mölnlycke aims to source 100% renewable electricity by 2024, increasing from 23% in 2021. The company is also committed to reaching net-zero emissions across its value chain by 2050, with specific targets for reducing emissions per ton of sold product by 97% within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a strong commitment to sustainability within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 31,751,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 50,910,000 | 00,000,000 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 200 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Molnlycke's Scope 3 emissions, which increased by 9% last year and increased significantly since 2017, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 64% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Molnlycke has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Molnlycke's sustainability data and climate commitments